On Friday, Alkermes plc (NASDAQ: ALKS) was 3.90% up from the session before settling in for the closing price of $27.70. A 52-week range for ALKS has been $22.22 – $32.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.61% over the last five years. When this article was written, the company’s average yearly earnings per share was at 82.21%. With a float of $158.75 million, this company’s outstanding shares have now reached $166.98 million.
The firm has a total of 2100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 82.31%, operating margin of 20.77%, and the pretax margin is 22.07%.
Alkermes plc (ALKS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Alkermes plc stocks. The insider ownership of Alkermes plc is 1.89%, while institutional ownership is 110.97%. The most recent insider transaction that took place on Nov 11 ’24, was worth 1,774,576. In this transaction EVP R&D, Chief Medical Officer of this company sold 58,996 shares at a rate of $30.08, taking the stock ownership to the 83,300 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Officer proposed sale 58,996 for $30.08, making the entire transaction worth $1,774,578.
Alkermes plc (ALKS) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.22 earnings per share (EPS) during the time that was less than consensus figure (set at 0.46) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.21% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
You can see what Alkermes plc (ALKS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.21. Likewise, its price to free cash flow for the trailing twelve months is 15.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.96, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 1.78 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Analysing the last 5-days average volume posted by the [Alkermes plc, ALKS], we can find that recorded value of 1.72 million was lower than the volume posted last year of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 31.97%. Additionally, its Average True Range was 0.96.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 79.46%, which indicates a significant increase from 52.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.74% in the past 14 days, which was higher than the 36.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.88, while its 200-day Moving Average is $26.60. Now, the first resistance to watch is $29.41. This is followed by the second major resistance level at $30.05. The third major resistance level sits at $30.96. If the price goes on to break the first support level at $27.86, it is likely to go to the next support level at $26.95. Should the price break the second support level, the third support level stands at $26.31.
Alkermes plc (NASDAQ: ALKS) Key Stats
There are 161,803K outstanding shares of the company, which has a market capitalization of 4.84 billion. As of now, sales total 1,663 M while income totals 355,760 K. Its latest quarter income was 378,140 K while its last quarter net income were 92,380 K.
